Search Results - "Copsel, S"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    P-020Targeting multidrug resistance - associated protein 4 (MRP4/ABCC4) in pancreatic cancer

    P-020Targeting multidrug resistance - associated protein 4 (MRP4/ABCC4) in pancreatic cancer by May, M, Alejandro, C, Gomez, N, Diez, F, Copsel, S, Iturbe, J, Mohr, N, Fernandez, N, Shayo, C, Davio, C

    Published in Annals of oncology (01-06-2016)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Marked in vivo Donor Treg expansion via targeting of the IL-2/CD25 and TL1A/TNFRSF25 pathways ameliorates GVHD and preserves GVL

    Marked in vivo Donor Treg expansion via targeting of the IL-2/CD25 and TL1A/TNFRSF25 pathways ameliorates GVHD and preserves GVL by Wolf, D, Barreras, H, Bader, C, Copsel, S, Lightbourn, C, Pfeiffer, B, Podack, E.R, Komanduri, K.V, Levy, R.B

    Published in Cytotherapy (Oxford, England) (01-05-2017)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    P-020 Targeting multidrug resistance – associated protein 4 (MRP4/ABCC4) in pancreatic cancer

    P-020 Targeting multidrug resistance – associated protein 4 (MRP4/ABCC4) in pancreatic cancer by May, M., Alejandro, C., Gomez, N., Diez, F., Copsel, S., Iturbe, J., Mohr, N., Fernandez, N., Shayo, C., Davio, C.

    Published in Annals of oncology (01-06-2016)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    13 - Marked in vivo Donor Treg expansion via targeting of the IL-2/CD25 and TL1A/TNFRSF25 pathways ameliorates GVHD and preserves GVL

    13 - Marked in vivo Donor Treg expansion via targeting of the IL-2/CD25 and TL1A/TNFRSF25 pathways ameliorates GVHD and preserves GVL by Wolf, D., Barreras, H., Bader, C., Copsel, S., Lightbourn, C., Pfeiffer, B., Podack, E.R., Komanduri, K.V., Levy, R.B.

    Published in Cytotherapy (Oxford, England) (01-05-2017)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: